Drugplain

DECONEX DMX 17.5 mg/1

Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride · TABLET · Poly Pharmaceuticals, Inc.

No Recall History
Plain English

DECONEX DMX is a tablet containing dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride at 17.5 mg/1, taken oral. Manufactured by Poly Pharmaceuticals, Inc..

Key Facts

Brand Name
DECONEX DMX
Generic Name
Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
NDC Code (Product)
50991-740
Manufacturer
Poly Pharmaceuticals, Inc.
Strength
17.5 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
06/01/2019

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

chronic kidney disease13 reports
renal failure7 reports
acute kidney injury5 reports
nephrogenic anaemia4 reports
tubulointerstitial nephritis4 reports
diarrhoea3 reports
end stage renal disease3 reports
fatigue3 reports
pain3 reports
rash3 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: cough due to minor throat and bronchial irritation helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive nasal congestion reduces swelling of nasal passages

Dosage & Administration

Directions Do not exceed recommended dosage. Adults and children 12 years of age and over: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours Children 6 to under 12 years of age: 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours Children under 6 years of age: Consult a physician.

Warnings

Warnings Do not exceed recommended dosage. Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema a cough that occurs with too much phlegm (mucus) heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition. new symptoms occur If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Frequently Asked Questions

What is DECONEX DMX used for?

DECONEX DMX contains Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride. It is a tablet taken oral. Consult your doctor for specific uses.

Is DECONEX DMX a controlled substance?

DECONEX DMX is not classified as a controlled substance by the DEA.

What is the generic name for DECONEX DMX?

The generic name for DECONEX DMX is Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride. There are 11 other brand versions of Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride.

What is the NDC code for DECONEX DMX 17.5 mg/1?

The NDC (National Drug Code) for DECONEX DMX 17.5 mg/1 is 50991-740, listed by Poly Pharmaceuticals, Inc..

Product NDC

50991-740

Package NDC

50991-740-01

Other Dextromethorphan Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)